Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
This week, the FDA expanded the approval of Johnson & Johnson's ketamine-based nasal spray, Spravato.
This week, the FDA expanded the approval of Johnson & Johnson's ketamine-based nasal spray, Spravato.
What's Your Reaction?
/cdn.vox-cdn.com/uploads/chorus_asset/file/25830955/dremel_drill1.jpg)
